Efficacy of CeraVe® Moisturizing Cream on Skin Pruritus in Elderly Patients
Pruritus
About this trial
This is an interventional treatment trial for Pruritus
Eligibility Criteria
Inclusion Criteria: patients age≥60 years old(male or female). Clinician evaluates dry pruritus or patient complains of pruritus, which lasts for more than 1 month. Patients informed consent to the purpose and content of the research, willing to cooperate with follow-up observation. Have good communication and understanding skills. Patients are willing to share photos for medical research purpose. Exclusion Criteria: Patients with bacterial and/or viral infections in the acute phase of skin inflammation The affected area is complicated by other skin diseases that may affect the efficacy evaluation Those who are allergic to the ingredients of this product or with allergic constitution Patients who have severe heart, brain, lung, or liver damage. Those who have received systemic or local antiallergic drug treatment within 2 weeks before enrollment of this study. Those who attending other clinical drug trials within 4 weeks before enrollment of this study. Patients with a history of alcohol or drug abuse. Patients who are unwilling to sign the informed consent form, and those who are unwilling to cooperate.
Sites / Locations
- Zhongshan Hospital,Fudan UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Case group
Control Group
Routine treatment together with once applicating CeraVe® Moisturising Cream after daily bath.
Routine treatment together with once applicating Standard Cream after daily bath.